Peginterferon Beta-1A

5 trials LOncology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

0 Recruiting

4 Completed trials

4 Sponsors

10 Countries

Phase III

Phase II

Phase III: 4 Phase II: 1

Indications tested

Relapsing-remitting multiple sclerosis 2 Secondary progressive multiple sclerosis 2 Multiple sclerosis 1 Progressive multiple sclerosis 1 Primary progressive multiple sclerosis 1 Multiple sclerosis relapse 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 2 Antwerp University Hospital 1 Biogen Idec Research Limited 1 Novartis Pharma AG 1

All trials

5 total

DESIRE MS: A prospective randomized non-inferiority trial comparing anti-CD20 maintenance versus De-Escalation Strategy In Relapsing-Remitti… Pending

2024-513292-40-00 Phase III 1 country Centre Hospitalier Universitaire De Montpellier
Metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration: a phase IIb triple-blind placeb… Ended

2023-503190-38-00 Phase II 1 country Antwerp University Hospital
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon beta-1a) in Pediatric Participants for the Treatment of… Ended

2023-505624-56-00 Phase III 5 countries Biogen Idec Research Limited
STOP-I-SEP_Disease modifying therapies withdrawal in inactive Secondary Progressive Multiple Sclerosis patients older than 50 years Ended

2024-516628-32-00 Phase III 1 country Centre Hospitalier Universitaire De Rennes
Study of efficacy and tolerability of ofatumumab vs. First Line disease modifying treatment (DMT) - physician’s choice in the treatment of n… Ended

2023-507431-37-00 Phase III 4 countries Novartis Pharma AG

Showing 1–5 of 5 trials

← All drugs A–Z